Pharmaceutical company
Active 2021–2026. The register lists this client once for every firm that files on its behalf; all 2 of its records are shown together here.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2026 | BALLARD PARTNERS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$120,000 | |
| 2026 | BALLARD PARTNERS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$120,000 | |
| 2026 | BALLARD PARTNERS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$40,000 | |
| 2026 | BALLARD PARTNERS |
1st Quarter (Jan 1 - Mar 31) Registration |
— | |
| 2022 | SQUIRE PATTON BOGGS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Termination (No Activity) |
— | |
| 2021 | SQUIRE PATTON BOGGS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report (No Activity) |
— | |
| 2021 | SQUIRE PATTON BOGGS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report (No Activity) |
— | |
| 2021 | SQUIRE PATTON BOGGS |
1st Quarter (Jan 1 - Mar 31) AMENDED |
— | |
| 2021 | SQUIRE PATTON BOGGS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report (No Activity) |
— | |
| 2021 | SQUIRE PATTON BOGGS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$90,000 |
| Firm | Filings | Amount |
|---|---|---|
| BALLARD PARTNERS | 4 | $280,000 |
| SQUIRE PATTON BOGGS | 7 | — |
| Issue | Activities |
|---|---|
| Trade (domestic/foreign) | 4 |
| Manufacturing | 3 |
| Health Issues | 2 |